PMA P990040
- Device
- TRUFILL n-BCA Liquid Embolic System
- Applicant
- Cerenovus, Inc.
- PMA number
- P990040
- Supplement
- S029
- Product code
- KGG
- Decision date
- 2026-10-23
- Classification
- Tissue Adhesive For Use In Embolization Of Brain Arteriovenous Malformations
- Generic name
- tissue adhesive for use in embolization of brain arteriovenous malformations
- Approval order statement
- Approval of the protocol for the TRUFILL post-approval study (PAS). The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P990040/S034.
Current openFDA PMA Record#
- Device
- TRUFILL n-BCA Liquid Embolic System
- Applicant
- Cerenovus, Inc.
- PMA number
- P990040
- Supplement
- S037
- Product code
- KGG
- Generic name
- tissue adhesive for use in embolization of brain arteriovenous malformations
- Decision date
- 2026-10-23
- Decision code
- APPR
- Date received
- 2026-02-02
- Supplement type
- Normal 180 Day Track No User Fee
- Supplement reason
- Postapproval Study Protocol
- Approval order statement
- Approval of the protocol for the TRUFILL post-approval study (PAS). The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P990040/S034.